| Jesse Walker, DO | |
|
8074 S 1300 E, Sandy, UT 84094-0743 | |
| (925) 330-5535 | |
| Not Available |
| Full Name | Jesse Walker |
|---|---|
| Gender | Male |
| Speciality | Physical Medicine And Rehabilitation |
| Experience | 6 Years |
| Location | 8074 S 1300 E, Sandy, Utah |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1417452046 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208100000X | Physical Medicine & Rehabilitation | 11420247-1204 (Utah) | Primary |
| Entity Name | Claris Health Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356797070 PECOS PAC ID: 5496097396 Enrollment ID: O20200328000186 |
News Archive
Advanced Biomaterial Systems, Inc. (ABS) has received U.S. patent 6,984,063 for an Apparatus for Mixing and Dispensing Components. This patent is a continuation of several patents which incorporate twistOR and Plexis technology.
Epeius Biotechnologies (www.epeiusbiotech.com) announces the completion of the design engineering and construction phase of a state-of-the-art Vector Production Unit (VPU) for the commercial manufacturing of its advanced targeted genetic medicines. In accordance with an FDA Critical Path initiative, which encourages innovation and the implementation of new technological advances in GMP, CMC, aseptic processing, and quality control, the Epeius VPU is poised to launch the large-scale production of targeted genetic medicine into the 21st century.
Santen Inc., the U.S. subsidiary of global ophthalmic pharmaceutical company Santen Pharmaceutical Co., Ltd. (Osaka, Japan), today announced that SAKURA (Study Assessing double‐masKed Uveitis tReAtment) Study 1, the first of two Global Phase III studies evaluating intravitreal injections of sirolimus in patients with non-infectious posterior segment uveitis (NI-PSU), met its primary endpoint.
The Association of British HealthTech Industries is offering UK companies the opportunity to take part in a number of US-based activities designed to help them access the US market.
› Verified 8 days ago
| Entity Name | Utah Modern Medical Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689310948 PECOS PAC ID: 8729461728 Enrollment ID: O20220823003069 |
News Archive
Advanced Biomaterial Systems, Inc. (ABS) has received U.S. patent 6,984,063 for an Apparatus for Mixing and Dispensing Components. This patent is a continuation of several patents which incorporate twistOR and Plexis technology.
Epeius Biotechnologies (www.epeiusbiotech.com) announces the completion of the design engineering and construction phase of a state-of-the-art Vector Production Unit (VPU) for the commercial manufacturing of its advanced targeted genetic medicines. In accordance with an FDA Critical Path initiative, which encourages innovation and the implementation of new technological advances in GMP, CMC, aseptic processing, and quality control, the Epeius VPU is poised to launch the large-scale production of targeted genetic medicine into the 21st century.
Santen Inc., the U.S. subsidiary of global ophthalmic pharmaceutical company Santen Pharmaceutical Co., Ltd. (Osaka, Japan), today announced that SAKURA (Study Assessing double‐masKed Uveitis tReAtment) Study 1, the first of two Global Phase III studies evaluating intravitreal injections of sirolimus in patients with non-infectious posterior segment uveitis (NI-PSU), met its primary endpoint.
The Association of British HealthTech Industries is offering UK companies the opportunity to take part in a number of US-based activities designed to help them access the US market.
› Verified 8 days ago
| Entity Name | Jesse Walker Do Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154059228 PECOS PAC ID: 0547634453 Enrollment ID: O20230316000088 |
News Archive
Advanced Biomaterial Systems, Inc. (ABS) has received U.S. patent 6,984,063 for an Apparatus for Mixing and Dispensing Components. This patent is a continuation of several patents which incorporate twistOR and Plexis technology.
Epeius Biotechnologies (www.epeiusbiotech.com) announces the completion of the design engineering and construction phase of a state-of-the-art Vector Production Unit (VPU) for the commercial manufacturing of its advanced targeted genetic medicines. In accordance with an FDA Critical Path initiative, which encourages innovation and the implementation of new technological advances in GMP, CMC, aseptic processing, and quality control, the Epeius VPU is poised to launch the large-scale production of targeted genetic medicine into the 21st century.
Santen Inc., the U.S. subsidiary of global ophthalmic pharmaceutical company Santen Pharmaceutical Co., Ltd. (Osaka, Japan), today announced that SAKURA (Study Assessing double‐masKed Uveitis tReAtment) Study 1, the first of two Global Phase III studies evaluating intravitreal injections of sirolimus in patients with non-infectious posterior segment uveitis (NI-PSU), met its primary endpoint.
The Association of British HealthTech Industries is offering UK companies the opportunity to take part in a number of US-based activities designed to help them access the US market.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jesse Walker, DO 1611 E Spring Run Dr, Holladay, UT 84117-6956 Ph: (925) 330-5535 | Jesse Walker, DO 8074 S 1300 E, Sandy, UT 84094-0743 Ph: (925) 330-5535 |
News Archive
Advanced Biomaterial Systems, Inc. (ABS) has received U.S. patent 6,984,063 for an Apparatus for Mixing and Dispensing Components. This patent is a continuation of several patents which incorporate twistOR and Plexis technology.
Epeius Biotechnologies (www.epeiusbiotech.com) announces the completion of the design engineering and construction phase of a state-of-the-art Vector Production Unit (VPU) for the commercial manufacturing of its advanced targeted genetic medicines. In accordance with an FDA Critical Path initiative, which encourages innovation and the implementation of new technological advances in GMP, CMC, aseptic processing, and quality control, the Epeius VPU is poised to launch the large-scale production of targeted genetic medicine into the 21st century.
Santen Inc., the U.S. subsidiary of global ophthalmic pharmaceutical company Santen Pharmaceutical Co., Ltd. (Osaka, Japan), today announced that SAKURA (Study Assessing double‐masKed Uveitis tReAtment) Study 1, the first of two Global Phase III studies evaluating intravitreal injections of sirolimus in patients with non-infectious posterior segment uveitis (NI-PSU), met its primary endpoint.
The Association of British HealthTech Industries is offering UK companies the opportunity to take part in a number of US-based activities designed to help them access the US market.
› Verified 8 days ago
Kim Marie Mckinnon, NP Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 45 W Sego Lily Dr Ste 312, Sandy, UT 84070 Phone: 801-676-9452 Fax: 801-206-9734 | |
Anina Merrill, M.D. Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 8074 S 1300 E, Sandy, UT 84094 Phone: 801-565-6500 Fax: 801-565-6774 | |
Michael Thomas Giovanniello, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 10011 S Centennial Pkwy, Ste 500, Sandy, UT 84070 Phone: 801-676-7627 Fax: 801-676-7630 | |
Stephen P Marble, MD Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 8074 S 1300 E, Sandy, UT 84094 Phone: 801-565-6500 Fax: 801-565-6501 | |
Dr. Joseph Clark Fyans, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 9450 S 1300 E, Suite 120, Sandy, UT 84094 Phone: 801-294-6907 Fax: 801-294-6917 | |
Michael Ming-chi Chen, D.O. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 11333 S 1000 E, Suite 102, Sandy, UT 84094 Phone: 801-462-2205 |